Indivior Pharmaceuticals, Inc. financial data

Symbol
INDV on Nasdaq
Location
North Chesterfield, VA
Fiscal year end
23 January
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 86% %
Quick Ratio 16% %
Debt-to-equity -743% %
Return On Equity -99% % -3757%
Return On Assets 15% %
Operating Margin 21% % 561%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 125,065,242 shares
Common Stock, Value, Issued $62,000,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 125,000,000 shares -5.3%
Weighted Average Number of Shares Outstanding, Diluted 128,000,000 shares -3.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,239,000,000 USD 4.3%
Operating Income (Loss) $262,000,000 USD 589%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $239,000,000 USD 1095%
Income Tax Expense (Benefit) $29,000,000 USD 123%
Net Income (Loss) Attributable to Parent $210,000,000 USD 2900%
Earnings Per Share, Basic 1.68 USD/shares 3260%
Earnings Per Share, Diluted 1.64 USD/shares 3180%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $195,000,000 USD -39%
Accounts Receivable, after Allowance for Credit Loss, Current $253,000,000 USD -0.39%
Inventory, Net $153,000,000 USD -8.4%
Other Assets, Current $16,000,000 USD -24%
Assets, Current $652,000,000 USD -21%
Deferred Income Tax Assets, Net $323,000,000 USD 17%
Property, Plant and Equipment, Net $144,000,000 USD 44%
Operating Lease, Right-of-Use Asset $26,000,000 USD -33%
Goodwill $2,000,000 USD 0%
Other Assets, Noncurrent $27,000,000 USD -31%
Assets $1,201,000,000 USD -8.7%
Accounts Payable, Current $48,000,000 USD -24%
Employee-related Liabilities, Current $103,000,000 USD 72%
Liabilities, Current $914,000,000 USD -1.1%
Operating Lease, Liability, Noncurrent $22,000,000 USD -31%
Other Liabilities, Noncurrent $21,000,000 USD 17%
Liabilities $1,300,000,000 USD -21%
Accumulated Other Comprehensive Income (Loss), Net of Tax $30,000,000 USD 17%
Retained Earnings (Accumulated Deficit) $243,000,000 USD 45%
Stockholders' Equity Attributable to Parent $98,000,000 USD 71%
Liabilities and Equity $1,201,000,000 USD -8.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares, Issued 125,000,000 shares 0%
Common Stock, Par or Stated Value Per Share 0.5 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $195,000,000 USD -39%
Deferred Tax Assets, Valuation Allowance $55,000,000 USD 17%
Deferred Tax Assets, Gross $381,000,000 USD 15%
Operating Lease, Liability $32,000,000 USD -24%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $216,000,000 USD 21500%
Lessee, Operating Lease, Liability, to be Paid $37,000,000 USD -26%
Property, Plant and Equipment, Gross $251,000,000 USD 32%
Operating Lease, Liability, Current $10,000,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two $11,000,000 USD -8.3%
Lessee, Operating Lease, Liability, to be Paid, Year One $12,000,000 USD -7.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -12%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5,000,000 USD -38%
Lessee, Operating Lease, Liability, to be Paid, Year Three $8,000,000 USD -27%
Deferred Tax Assets, Operating Loss Carryforwards $128,000,000 USD -16%
Unrecognized Tax Benefits $5,000,000 USD 25%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,000,000 USD -86%
Additional Paid in Capital $112,000,000 USD 24%
Deferred Tax Assets, Net of Valuation Allowance $326,000,000 USD 15%
Share-based Payment Arrangement, Expense $26,000,000 USD 8.3%